Trial Profile
Healing Response to Everolimus-eluting Stent Implantation; Serial Assessment With opticaL Coherence Tomography.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms HEAL
- 06 Sep 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Sep 2012 New trial record